BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33729861)

  • 21. Differential Diagnosis of Malignant Pleural Mesothelioma on Cytology: A Gene Expression Panel versus BRCA1-Associated Protein 1 and p16 Tests.
    Bruno R; Alì G; Poma AM; Proietti A; Libener R; Mariani N; Niccoli C; Chella A; Ribechini A; Grosso F; Fontanini G
    J Mol Diagn; 2020 Apr; 22(4):457-466. PubMed ID: 32036091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue.
    Hida T; Matsumoto S; Hamasaki M; Kawahara K; Tsujimura T; Hiroshima K; Kamei T; Taguchi K; Iwasaki A; Oda Y; Honda H; Nabeshima K
    Cancer Sci; 2015 Nov; 106(11):1635-41. PubMed ID: 26291840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FISH analysis of intrapulmonary malignant mesothelioma without a clinically detectable primary pleural lesion: an autopsy case.
    Hasegawa M; Sakai F; Sato A; Tsubomizu S; Arimura K; Katsura H; Koh E; Sekine Y; Wu D; Hiroshima K
    Jpn J Clin Oncol; 2014 Dec; 44(12):1239-42. PubMed ID: 25425731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sarcomatoid mesothelioma originating from mesothelioma in situ: are methylthioadenosine phosphorylase loss and CDKN2A homozygous deletion poor prognostic factors for preinvasive mesothelioma?
    Nishikubo M; Jimbo N; Tanaka Y; Tachihara M; Itoh T; Maniwa Y
    Virchows Arch; 2022 Aug; 481(2):307-312. PubMed ID: 35043235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma.
    Chapel DB; Dubuc AM; Hornick JL; Sholl LM
    Histopathology; 2021 Jun; 78(7):1032-1042. PubMed ID: 33387364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of FISH signal cut-off values for 9p21 deletion in malignant pleural mesothelioma: Is it underestimated?
    Kulduk G; Ekinci Ö; Toker G; Demirci U; Özaydın E; Akyürek N; Memiş L
    Pathol Res Pract; 2019 Jun; 215(6):152377. PubMed ID: 30885529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic mesothelioma biomarkers in effusion cytology.
    Eccher A; Girolami I; Lucenteforte E; Troncone G; Scarpa A; Pantanowitz L
    Cancer Cytopathol; 2021 Jul; 129(7):506-516. PubMed ID: 33465294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas.
    Hwang HC; Pyott S; Rodriguez S; Cindric A; Carr A; Michelsen C; Thompson K; Tse CH; Gown AM; Churg A
    Am J Surg Pathol; 2016 May; 40(5):714-8. PubMed ID: 26900815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distant cutaneous metastasis of malignant epithelioid mesothelioma.
    Collins K; Nagarajan P; Aung PP
    J Cutan Pathol; 2021 Jul; 48(7):902-907. PubMed ID: 33258154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas.
    Dacic S; Kothmaier H; Land S; Shuai Y; Halbwedl I; Morbini P; Murer B; Comin C; Galateau-Salle F; Demirag F; Zeren H; Attanoos R; Gibbs A; Cagle P; Popper H
    Virchows Arch; 2008 Dec; 453(6):627-35. PubMed ID: 18958493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rare case of primary gastric Burkitt's lymphoma associated with malignant pleural mesothelioma.
    Spaziani E; Di Filippo AR; Valle G; Spaziani M; Francioni P; Caruso G; Tamagnini GT; Mosciatti E; Picchio M; De Cesare A
    Ann Ital Chir; 2023 Mar; 12():. PubMed ID: 36924064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant pleural mesothelioma with scalp, cerebellar, and finger metastases: a rare case.
    Kanbay A; Oguzulgen KI; Ozturk C; Memis L; Demircan S; Kurkcuoglu C; Akyurek N; Kurul C
    South Med J; 2007 Jan; 100(1):63-5. PubMed ID: 17269529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma.
    Pillappa R; Maleszewski JJ; Sukov WR; Bedroske PP; Greipp PT; Boland JM; Yi ES; Peikert T; Aubry MC; Roden AC
    Am J Surg Pathol; 2018 Feb; 42(2):256-263. PubMed ID: 29076876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
    Wagner D; Bourne PA; Yang Q; Goldman BI; Lewis JS; Xu H
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):301-7. PubMed ID: 18301236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma.
    Chung CT; Santos Gda C; Hwang DM; Ludkovski O; Pintilie M; Squire JA; Tsao MS
    J Clin Pathol; 2010 Jul; 63(7):630-4. PubMed ID: 20591913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous Presentation of Mesothelioma With a Sarcomatoid Transformation.
    Klebanov N; Reddy BY; Husain S; Silvers DN; Grossman ME; Tsao H
    Am J Dermatopathol; 2018 May; 40(5):378-382. PubMed ID: 29059099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of BRCA-1-associated protein 1 expression and cyclin-dependent kinase inhibitor 2A deletion to distinguish peritoneal malignant mesothelioma from peritoneal location of carcinoma in effusion cytology specimens.
    Althakfi W; Gazzo S; Blanchet M; Isaac S; Piaton E; Villeneuve L; Glehen O; Gilly FN; Brevet M
    Cytopathology; 2020 Jan; 31(1):5-11. PubMed ID: 31713897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse intrapulmonary mesothelioma mimicking pulmonary lepidic adenocarcinoma: a rare case report and review of the literature.
    RanYue W; ChunYan W; Likun H; LiPing Z; JieLu L; ZhengWei D
    Diagn Pathol; 2023 May; 18(1):64. PubMed ID: 37194050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens.
    Hwang HC; Sheffield BS; Rodriguez S; Thompson K; Tse CH; Gown AM; Churg A
    Am J Surg Pathol; 2016 Jan; 40(1):120-6. PubMed ID: 26448191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.